POLARYX THERAPEUTICS, INC. (PLYX)
Polaryx Therapeutics Announces Closing of $10 Million Private Placement Equity Financing to Support Launch of SOTERIA Phase 2 Basket Trial
Polaryx Therapeutics Announces Closing of $10 Million Private Placement Equity Financing to Support Launch of SOTERIA Phase 2 Basket Trial
Vor Bio to Participate in the 2026 Jefferies Global Healthcare Conference
BlackSky Secures Seven-Figure, Multi-Year Renewal Contract to Accelerate Automation of Future Non-Earth Imagery Services
Hongli Group Inc. Engages Battery Technology Expert Dr. Phillip A. Medina IV as Independent Technical Advisor for Energy Storage Initiatives
XTEND Selected for Phase II Qualifier of U.S. Department of Defense $1 Billion Drone Dominance Program
Redfin Reports Investor Home Purchases Fall to Lowest Level Since 2020
Celcuity To Participate in Upcoming Investor Conferences
Tempus Expands Next Platform to Deliver Real-Time Clinical Intelligence and Close Critical Care Gaps Across Oncology
NewGen Executes Share Purchase Agreement and Obtains Exclusive APAC Agency Rights with K25.ai, an AI-Powered Prediction Market Led by Industry Veteran Andy Cheung
Cintas Earns Newsweek’s Most Trustworthy Companies in America 2026 Award